Universal Health Services (NYSE:UHS) reported Q2 CY2025 results, with revenue up 9.6% to $4.28 billion, beating expectations. Non-GAAP profit was $5.35 per share, 8.4% above estimates. Full year revenue is expected to reach $17.2 billion. The company operates hospitals and behavioral health facilities across 39 states and three countries. Over the last five years, revenue growth averaged 7.9%, while EPS grew at 14.7%. In Q2, operating margin was 11.7%. Universal Health Services’s stock price remained flat at $154.70 post-reporting. Analysts forecast 6.8% revenue growth in the next 12 months.

Read more at StockStory: Universal Health Services’s (NYSE:UHS) Q2 Sales Beat Estimates